References
- 1. Parisi, R., Symmons, D.P.M., Griffiths, C.E.M. & Ashcroft, D.M. (2013). Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence. J Invest Dermatol. 133(2), 377-385. doi: http://www.nature.com/jid/journal/v133/n2/suppinfo/jid2012339s1.html10.1038/jid.2012.33923014338
- 2. Meffert, J. & James, W.D. (2015, December). Psoriasis Clinical Presentation. Retrieved December, 2015, from http://emedicine.medscape.com/article/1943419-clinical#showall
- 3. Naldi, L., Svensson, A., Diepgen, T., Elsner, P., Grob, J.J., Coenraads, P.J., Bavinck, J.N., Williams, H. & European Dermato- Epidemiology, N. (2003). Randomized clinical trials for psoriasis 1977-2000: the EDEN survey. J Invest Dermatol. 120(5), 738-741. doi: 10.1046/j.1523-1747.2003.12145.x10.1046/j.1523-1747.2003.12145.x12713574
- 4. Fredriksson, T. & Pettersson, U. (1978). Severe psoriasis--oral therapy with a new retinoid. Dermatologica. 157(4), 238-244.10.1159/000250839357213
- 5. Youn, S.W., Choi, C.W., Kim, B.R. & Chae, J.B. (2015). Reduction of Inter-Rater and Intra-Rater Variability in Psoriasis Area and Severity Index Assessment by Photographic Training. Annals of Dermatology. 27(5), 557-562. doi: 10.5021/ ad.2015.27.5.55710.5021/ad.2015.27.5.557462289026512170
- 6. Carlin, C.S., Feldman, S.R., Krueger, J.G., Menter, A. & Krueger, G.G. (2004). A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol. 50(6), 859-866. doi: 10.1016/j. jaad.2003.09.014
- 7. Harari, M., Shani, J., Hristakieva, E., Stanimirovic, A., Seidl, W. & Burdo, A. 2000). Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead-Sea. Int J Dermatol. 39(12), 913-918.10.1046/j.1365-4362.2000.00017.x11168660
- 8. Evidence Update Advisory Group. (2014). Psoriasis - Evidence Update November 2014 The assessment and management of psoriasis (Vol. 68). National Institute for Health and Care Excellence.
- 9. Ihtatho, D., Fadzil, M.H., Affandi, A.M. & Hussein, S.H. (2007). Area assessment of psoriasis lesion for PASI scoring. Conf Proc IEEE Eng Med Biol Soc. 2007, 3446-3449. doi: 10.1109/IEMBS.2007.435307210.1109/IEMBS.2007.435307218002738
- 10. Ahmad Fadzil, M.H., Ihtatho, D., Mohd Affandi, A. & Hussein, S.H. (2009). Objective assessment of psoriasis erythema for PASI scoring. J Med Eng Technol. 33(7), 516-524. doi: 10.1080/0743461090274407410.1080/0743461090274407419639508
- 11. Henseler, T. & Schmitt-Rau, K. (2008). A comparison between BSA, PASI, PLASI and SAPASI as measures of disease severity and improvement by therapy in patients with psoriasis. Int J Dermatol. 47(10), 1019-1023. doi: 10.1111/j.1365-4632.2008.03753.x10.1111/j.1365-4632.2008.03753.x18986347
- 12. Gottlieb, A.B., Chaudhari, U., Baker, D.G., Perate, M. & Dooley, L.T. (2003). The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician’s Global Assessment (PGA): a comparison. J Drugs Dermatol. 2(3), 260-266.
- 13. Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemeny, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N. & Yawalkar, N. (2015). European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC. J Eur Acad Dermatol Venereol. 29(12), 2277-2294. doi: 10.1111/jdv.1335410.1111/jdv.1335426481193
- 14. Bhor, U. & Pande, S. (2006). Scoring systems in dermatology. Indian J Dermatol Venereol Leprol. 72(4), 315-321. 10.4103/0378-6323.2672216880586